appDr. Lal PathLabs Ltd
ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD
Stock has been generating better return on equity than bank FD
Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company
Stock doesn't offer attractive dividend returns
Entry pointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock
Good time to consider, as stock is not in overbought zone
No Red FlagsASM and GSM lists are measures to safeguard investors against volatility and unjustified stock prices. Pledging holdings means taking loans against held promoter shares. Stocks in ASM/GSM list or with high pledged promoter holding should be handled with caution. Unsolicited tips are sometimes circulated to manipulate the market. Beware of these stocks
Stock not in ASM/GSM lists and not a lot of promoter holding is pledged
Dr. Lal PathLabs Ltd
LALPATHLAB
Price Chart
Intrinsic valueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Current price is more than the intrinsic value
ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD
Stock has been generating better return on equity than bank FD
Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company
Stock doesn't offer attractive dividend returns
Entry pointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock
Good time to consider, as stock is not in overbought zone
No Red FlagsASM and GSM lists are measures to safeguard investors against volatility and unjustified stock prices. Pledging holdings means taking loans against held promoter shares. Stocks in ASM/GSM list or with high pledged promoter holding should be handled with caution. Unsolicited tips are sometimes circulated to manipulate the market. Beware of these stocks
Stock not in ASM/GSM lists and not a lot of promoter holding is pledged
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Analysts have suggested that investors can buy this stock
Company Profile
Dr Lal Pathlabs Private Limited is headquartered in Gurgaon, Haryana, India and is a medical laboratory operator.
Brands
Investor PresentationView older
View Older PresentationsBrands
PeersCompare with peers
Apollo Hospitals Enterprise Ltd
Max Healthcare Institute Ltd
Fortis Healthcare Ltd
Narayana Hrudayalaya Ltd
Krishna Institute of Medical Sciences Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Financial TrendFinancial statements
Holdings TrendDetailed holdings
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent NewsAll news
Buy Dr. Lal Pathlabs, target price Rs 2820: BNP Paribas Securities
2 weeks ago•Economic Times
CARE Ratings assigns “AA” rating to Dr. Lal PathLabs
3 weeks ago•Business Standard
Lal PathLabs targets leadership position in west India in 5 years
3 weeks ago•Business Standard
Recent EventsAll events
Acquisition
Please take note that the Board of Directors of PathLabs Unifiers Private Limited ( PUPL ) (a Wholly Owned Subsidiary of the Company) in their meeting on January 30, 2023 approved the acquisition of further 10% equity stake in its Subsidiary Company i.e. APRL PathLabs Private Limited ( APRL ). | Download
Please take note that the Board of Directors of PathLabs Unifiers Private Limited ( PUPL ) (a Wholly Owned Subsidiary of the Company) in their meeting on January 30, 2023 approved the acquisition of further 10% equity stake in its Subsidiary Company i.e. APRL PathLabs Private Limited ( APRL ). | Download
Analysts/Institutional Investor Meet/Con. Call Updates
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find attached the invite of the Conference Call for Investors/Analysts to be held on Thursday, February 02, 2023 at 05:00 pm IST to discuss the financial and operating performance for Q3 & 9M FY23. | Download
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find attached the invite of the Conference Call for Investors/Analysts to be held on Thursday, February 02, 2023 at 05:00 pm IST to discuss the financial and operating performance for Q3 & 9M FY23. | Download
Cash Dividend
Interim • Div/Share: ₹ 6
Intrinsic valueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Current price is more than the intrinsic value